Jazz Pharmaceuticals JAZZ Total debt

Total debt at other companies

AmgenAMGN

$57.3B+2.0%

AlkermesALKS

$1.57B+2,064%

Xenon PharmaceuticalsXENE

$6.42M-26.4%

Stoke Therapeutics, Inc.STOK

$3.42M-42.5%

Praxis Precision Medicines, Inc.PRAX

$1.09M+44.0%

Amneal Pharmaceuticals, Inc.AMRX

$2.57B+18.0%

FAQ

What is Jazz Pharmaceuticals's total debt?

Jazz Pharmaceuticals (JAZZ) reported total debt of $5.4B in Q1 2026.

How has Jazz Pharmaceuticals's total debt changed year-over-year?

Jazz Pharmaceuticals's total debt decreased by 0.1% year-over-year, from $5.41B to $5.4B.

What is the long-term trend for Jazz Pharmaceuticals's total debt?

Over 5 years (2020 to 2025), Jazz Pharmaceuticals's total debt has grown at a 19.3% compound annual growth rate (CAGR), from $2.25B to $5.43B.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.